Table 3.
In silico toxicity and endocrine disruption potential of THY and its derivatives.
| In silico methodology | Objective | Key findings | Conclusion | References | Year |
|---|---|---|---|---|---|
| Analysis using Osiris DataWarrior® software | To evaluate THY and derivatives toxicity | THY and its derivatives exhibit theoretical toxicity parameters similar to existing antibiotics. Derivatives show negative drug-likeness values, suggesting originality and potential to evade resistance mechanisms. THY is flagged as potentially mutagenic, tumorigenic, irritant, and likely to cause reproductive effects. | THY and derivatives present theoretical risks; however, derivative structures may retain efficacy against resistant strains due to their unique drug-likeness profiles. | (51) | 2020 |
| PreADMET | To predict the toxicological effects of THY and phytol isolated from Moringa oleifera | THY tests positive in the Ames test for mutagenicity in three strains. Phytol shows potential carcinogenicity in rats. | THY raises concerns regarding mutagenicity, while phytol may have carcinogenic effects. Further toxicological studies are necessary. | (52) | |
| Docking on interface for target system's platform | To assess THY endocrine disruption potential | THY shows low binding affinity to most endocrine receptors, except for antagonistic binding to the androgen receptor. | THY exhibits limited potential as an endocrine disruptor, though its effect on androgen receptors warrants further investigation. | (50) | 2021 |